Advancing innovative compound and new technology tools to treat rare and unmet medical needs. tBrexa BioSciences Inc. (tBrexa), is a privately held early-stage, preclinical biopharmaceutical company focused on the discovery, development, and commercialization of therapies that transform the treatment of challenging diseases.
